Loading...
Please wait, while we are loading the content...
Similar Documents
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
| Content Provider | Scilit |
|---|---|
| Author | Hahn, Deirdre Hodson, Elisabeth M. Hamiwka, Lorraine A. Lee, Vincent Ws Chapman, Jeremy R. Craig, Jonathan Webster, Angela C. |
| Copyright Year | 2019 |
| Description | Journal: Cochrane Database of Systematic Reviews |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953317/pdf https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004290.pub3/pdf/CDSR/CD004290/CD004290.pdf |
| ISSN | 1469493X |
| e-ISSN | 14651858 |
| DOI | 10.1002/14651858.cd004290.pub3 |
| Journal | Cochrane Database of Systematic Reviews |
| Issue Number | 12 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2019-12-16 |
| Access Restriction | Open |
| Subject Keyword | Journal: Cochrane Database of Systematic Reviews Tropical Medicine *immunosuppression *kidney Transplantation Immunosuppressive Agents [adverse Effects, *therapeutic Use] Randomized Controlled Trials As Topic Sirolimus [adverse Effects, *analogs & Derivatives, Antagonists & Inhibitors, *therapeutic Use] |
| Content Type | Text |
| Resource Type | Article |